跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Clinical manifestation and disease progression in COVID-19 infection
Ping Hsing Tsai
, Wei Yi Lai
, Yi Ying Lin
, Yung Hung Luo
,
Yi Tsung Lin
, Hsiao Kang Chen
, Yuh Min Chen
, Yi Chun Lai
, Li Chiao Kuo
, Shew Dan Chen
, Kao Jung Chang
, Cheng Hsuan Liu
, Shih Chieh Chang
*
, Fu Der Wang
*
, Yi Ping Yang
*
*
此作品的通信作者
急重症醫學研究所
研究成果
›
同行評審
140
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Clinical manifestation and disease progression in COVID-19 infection」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Clinical Disease
100%
Disease Progression
100%
Clinical Manifestations
100%
COVID-19
100%
Disease Severity
12%
Infectious Diseases
12%
Critically Ill Patients
12%
Air Droplets
12%
Illness
12%
Rash
12%
Gastrointestinal Diseases
12%
Poor Survival
12%
Necrotic Lesion
12%
Acute Kidney Injury
12%
General Clinical
12%
Clinical Symptoms
12%
Hepatobiliary
12%
Neurological Symptoms
12%
Cardiovascular Comorbidities
12%
Peripheral Nervous System
12%
Multiple Organ Failure
12%
Clinical Signs
12%
Cardiovascular Complications
12%
Disease Manifestations
12%
Hyperglycemia
12%
Acute Respiratory Distress Syndrome
12%
Skin Lesions
12%
Respiratory Failure
12%
Severe Pneumonia
12%
Cutaneous Manifestations
12%
Radiological Features
12%
Digestive
12%
Respiratory System Diseases
12%
Hepatic Function
12%
Petechiae
12%
Critically Illness
12%
Exanthematous
12%
Chilblain-like
12%
Euglycemic
12%
Pulmonary Symptoms
12%
Livedoid
12%
Vesicular Lesion
12%
Pernio
12%
Diabetic Ketoacidosis
12%
Maculopapular Rash
12%
Ketosis
12%
Extrapulmonary Involvement
12%
Medicine and Dentistry
Infection
100%
Disease Exacerbation
100%
COVID-19
100%
Diseases
62%
Cardiovascular System
25%
Pernio
25%
Cardiovascular Disease
12%
Acute Kidney Injury
12%
Liver Function
12%
Neurologic Disease
12%
Sensation
12%
Peripheral Nervous System
12%
Exanthem
12%
Respiratory Failure
12%
Hyperglycemia
12%
Acute Respiratory Distress Syndrome
12%
Skin Defect
12%
Physical Disease by Body Function
12%
Multiple Organ Dysfunction Syndrome
12%
Gastrointestinal Distress
12%
Punctate Hemorrhage
12%
Dermatological Agent
12%
Vesicular Rash
12%
Ketoacidosis
12%
Maculopapular Rash
12%
Diabetic Ketoacidosis
12%
Comorbidity
12%
Respiratory System
12%